vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Atlassian Corp (TEAM). Click either name above to swap in a different company.

Atlassian Corp is the larger business by last-quarter revenue ($1.6B vs $950.5M, roughly 1.7× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -2.7%, a 3.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 23.3%). Atlassian Corp produced more free cash flow last quarter ($168.5M vs $-6.0M).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

The Dragoneer Investment Group (Dragoneer) is an American investment firm based in San Francisco, California. The firm focuses on technology investments in both public and private markets globally.

ASTH vs TEAM — Head-to-Head

Bigger by revenue
TEAM
TEAM
1.7× larger
TEAM
$1.6B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+19.6% gap
ASTH
42.9%
23.3%
TEAM
Higher net margin
ASTH
ASTH
3.4% more per $
ASTH
0.7%
-2.7%
TEAM
More free cash flow
TEAM
TEAM
$174.5M more FCF
TEAM
$168.5M
$-6.0M
ASTH

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ASTH
ASTH
TEAM
TEAM
Revenue
$950.5M
$1.6B
Net Profit
$6.6M
$-42.6M
Gross Margin
85.0%
Operating Margin
1.9%
-3.0%
Net Margin
0.7%
-2.7%
Revenue YoY
42.9%
23.3%
Net Profit YoY
184.4%
-11.6%
EPS (diluted)
$0.12
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
TEAM
TEAM
Q4 25
$950.5M
$1.6B
Q3 25
$956.0M
$1.4B
Q2 25
$654.8M
$1.4B
Q1 25
$620.4M
$1.4B
Q4 24
$665.2M
$1.3B
Q3 24
$478.7M
$1.2B
Q2 24
$486.3M
Q1 24
$404.4M
$1.2B
Net Profit
ASTH
ASTH
TEAM
TEAM
Q4 25
$6.6M
$-42.6M
Q3 25
$373.0K
$-51.9M
Q2 25
$9.4M
$-23.9M
Q1 25
$6.7M
$-70.8M
Q4 24
$-7.8M
$-38.2M
Q3 24
$16.1M
$-123.8M
Q2 24
$19.2M
Q1 24
$14.8M
$12.8M
Gross Margin
ASTH
ASTH
TEAM
TEAM
Q4 25
85.0%
Q3 25
82.0%
Q2 25
83.1%
Q1 25
83.8%
Q4 24
82.7%
Q3 24
81.7%
Q2 24
Q1 24
82.1%
Operating Margin
ASTH
ASTH
TEAM
TEAM
Q4 25
1.9%
-3.0%
Q3 25
2.0%
-6.7%
Q2 25
3.1%
-2.1%
Q1 25
3.3%
-0.9%
Q4 24
0.1%
-4.5%
Q3 24
5.9%
-2.7%
Q2 24
6.2%
Q1 24
7.5%
1.5%
Net Margin
ASTH
ASTH
TEAM
TEAM
Q4 25
0.7%
-2.7%
Q3 25
0.0%
-3.6%
Q2 25
1.4%
-1.7%
Q1 25
1.1%
-5.2%
Q4 24
-1.2%
-3.0%
Q3 24
3.4%
-10.4%
Q2 24
3.9%
Q1 24
3.7%
1.1%
EPS (diluted)
ASTH
ASTH
TEAM
TEAM
Q4 25
$0.12
$-0.16
Q3 25
$0.01
$-0.20
Q2 25
$0.19
$-0.08
Q1 25
$0.14
$-0.27
Q4 24
$-0.14
$-0.15
Q3 24
$0.33
$-0.48
Q2 24
$0.40
Q1 24
$0.31
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
TEAM
TEAM
Cash + ST InvestmentsLiquidity on hand
$429.5M
$1.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$1.6B
Total Assets
$2.2B
$6.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
TEAM
TEAM
Q4 25
$429.5M
$1.6B
Q3 25
$463.4M
$2.8B
Q2 25
$342.1M
$2.9B
Q1 25
$260.9M
$3.0B
Q4 24
$290.8M
$2.5B
Q3 24
$350.3M
$2.2B
Q2 24
$327.7M
Q1 24
$337.3M
$2.1B
Stockholders' Equity
ASTH
ASTH
TEAM
TEAM
Q4 25
$779.3M
$1.6B
Q3 25
$775.5M
$1.4B
Q2 25
$765.5M
$1.3B
Q1 25
$745.4M
$1.4B
Q4 24
$712.7M
$1.2B
Q3 24
$704.6M
$1.0B
Q2 24
$678.9M
Q1 24
$653.5M
$1.1B
Total Assets
ASTH
ASTH
TEAM
TEAM
Q4 25
$2.2B
$6.2B
Q3 25
$2.2B
$5.7B
Q2 25
$1.4B
$6.0B
Q1 25
$1.3B
$5.9B
Q4 24
$1.4B
$5.4B
Q3 24
$1.3B
$5.0B
Q2 24
$1.3B
Q1 24
$1.2B
$5.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
TEAM
TEAM
Operating Cash FlowLast quarter
$-2.9M
$177.8M
Free Cash FlowOCF − Capex
$-6.0M
$168.5M
FCF MarginFCF / Revenue
-0.6%
10.6%
Capex IntensityCapex / Revenue
0.3%
0.6%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
TEAM
TEAM
Q4 25
$-2.9M
$177.8M
Q3 25
$10.0M
$128.7M
Q2 25
$90.9M
$375.3M
Q1 25
$16.6M
$652.7M
Q4 24
$-10.9M
$351.9M
Q3 24
$34.0M
$80.5M
Q2 24
$23.2M
Q1 24
$6.0M
$565.4M
Free Cash Flow
ASTH
ASTH
TEAM
TEAM
Q4 25
$-6.0M
$168.5M
Q3 25
$7.4M
$114.6M
Q2 25
$89.5M
$360.3M
Q1 25
$13.6M
$638.3M
Q4 24
$-13.5M
$342.6M
Q3 24
$31.7M
$74.3M
Q2 24
$20.4M
Q1 24
$5.6M
$554.9M
FCF Margin
ASTH
ASTH
TEAM
TEAM
Q4 25
-0.6%
10.6%
Q3 25
0.8%
8.0%
Q2 25
13.7%
26.0%
Q1 25
2.2%
47.0%
Q4 24
-2.0%
26.6%
Q3 24
6.6%
6.3%
Q2 24
4.2%
Q1 24
1.4%
46.7%
Capex Intensity
ASTH
ASTH
TEAM
TEAM
Q4 25
0.3%
0.6%
Q3 25
0.3%
1.0%
Q2 25
0.2%
1.1%
Q1 25
0.5%
1.1%
Q4 24
0.4%
0.7%
Q3 24
0.5%
0.5%
Q2 24
0.6%
Q1 24
0.1%
0.9%
Cash Conversion
ASTH
ASTH
TEAM
TEAM
Q4 25
-0.44×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×
44.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

TEAM
TEAM

Cloud Deployment Services$1.1B67%
Data Center Deployment$435.6M27%
Marketplace And Services Deployment$83.7M5%

Related Comparisons